A. Schatzberg

S. Kesler, A. Schatzberg, K. Mehta, 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Monoamine oxidase and catechol-o-methyltransferase enzyme activity and gene expression in response to sustained glucocorticoids

A. Schatzberg, S. Lindley, Xiao-mei She, 2005, Psychoneuroendocrinology.

The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain.

A. Schatzberg, E. Bird, P. Langlais, 1985, Life sciences.

Opioids in Psychiatric Disorders: Back to the Future?

A. Schatzberg, 2015, The American journal of psychiatry.

Development of New Psychopharmacological Agents for Depression and Anxiety.

A. Schatzberg, 2015, The Psychiatric clinics of North America.

Psychoanalytic Contribution to a Theory of Depression

A. Schatzberg, P. Isenberg, 1978 .

Stress Coping and Resilience Modeled in Mice

D. M. Lyons, A. Schatzberg, L. Lecea, 2017 .

Learning to cope with stress modulates anterior cingulate cortex stargazin expression in monkeys and mice

D. M. Lyons, Michelle Y. Cheng, D. Absher, 2016, Neurobiology of Learning and Memory.

The dexamethasone suppression test: identification of subtypes of depression.

T. C. Bond, A. Schatzberg, M. Sullivan, 1983, The American journal of psychiatry.

Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey (Saimiri sciureus)

D. M. Lyons, A. Schatzberg, K. Waggie, 2000, Journal of medical primatology.

Personality traits and medical outcome of cardiac illness.

A. Schatzberg, J. Reich, 2010, Journal of psychiatric research.

Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data.

J. Mooney, A. Schatzberg, J. Schildkraut, 1985, Journal of psychiatric research.

Nicotine patch and paroxetine for smoking cessation.

A. Schatzberg, S. Fortmann, J. Killen, 2000, Journal of consulting and clinical psychology.

Striatal dopamine D2/3 receptor regulation by stress inoculation in squirrel monkeys

D. M. Lyons, A. Schatzberg, Alex G. Lee, 2016, Neurobiology of Stress.

Stress inoculation modeled in mice

D. M. Lyons, A. Schatzberg, Christine L. Buckmaster, 2015, Translational Psychiatry.

Long-term management of depression.

A. Schatzberg, R. Hirschfeld, 1994, The American journal of medicine.

22 – Topographic Mapping in Depressed Patients

F. Duffy, A. Schatzberg, G. Elliott, 1986 .

Psychobiological Consequences of Social Relationships a

D. M. Lyons, A. Schatzberg, S. Levine, 1997, Annals of the New York Academy of Sciences.

Effeminacy. I. A quantitative rating scale

A. Schatzberg, M. Westfall, A. B. Blumetti, 1975, Archives of sexual behavior.

Effeminacy. II. Variation with social context

A. Schatzberg, M. Westfall, A. B. Blumetti, 1975, Archives of sexual behavior.

Cannabis and the Developing Adolescent Brain

A. Schatzberg, S. Tapert, Adina S. Fischer, 2020, Current Treatment Options in Psychiatry.

Restless Legs Syndrome : A Review of Diagnosis and Management

D. Kupfer, N. Kalin, A. Schatzberg, 2006 .

The Dexamethasone Suppression Test as a Discriminator among Subtypes of Psychotic Patients

A. Schatzberg, A. Rothschild, A. Rosenbaum, 1982, British Journal of Psychiatry.

Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence?

T. Robinson, A. Schatzberg, J. Killen, 2009, Addictive behaviors.

Course of Depression in Adults: Treatment Options

A. Schatzberg, 1996 .

Mitochondria DNA copy number, mitochondria DNA total somatic deletions, Complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder

H. Akil, A. Schatzberg, W. Bunney, 2022, Translational Psychiatry.

Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence

R. Myers, S. Potkin, H. Akil, 2017, Molecular Neuropsychiatry.

Fluctuating postdexamethasone cortisol levels in a patient with melancholia.

A. Schatzberg, A. Rothschild, 1982, The American journal of psychiatry.

An Algorithm for the Treatment of Major Depression and its Subtypes

A. Schatzberg, C. Debattista, 1994 .

Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.

A. Schatzberg, J. Schildkraut, P. Orsulak, 1980, Schizophrenia bulletin.

Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase

J. Mooney, A. Schatzberg, J. Schildkraut, 1988, Biological Psychiatry.

Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.

A. Schatzberg, J. Keller, K. Sudheimer, 2021, The American journal of psychiatry.

Trait Locus Brain HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders.

L. DeLisi, H. Akil, A. Schatzberg, 2016 .

The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.

A. Schatzberg, G. Murphy, H. Rodrigues, 2003, Biological psychiatry.

Impaired transactivation of the glucocorticoid receptor cloned from the Guyanese squirrel monkey

D. M. Lyons, A. Schatzberg, Zhaomei Zhang, 2000, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Norma Pugh, P. Murali Doraiswamy, Madhukar H. Trivedi, 2002, JAMA.

Clozapine response and plasma catecholamines and their metabolites

A. Schatzberg, A. Green, J. Schildkraut, 1993, Psychiatry Research.

Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions.

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1983, The American journal of psychiatry.

Erratum: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (Proceedings of the National Academy of Sciences of the United States of America (November 25, 2003) 100, 24 (14293-14296))

M. Thase, C. Nemeroff, M. Keller, 2005 .

Fibroblast growth factor 9 is a novel modulator of negative affect

Katherine E. Prater, D. Absher, R. Myers, 2015, Proceedings of the National Academy of Sciences.

Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.

A. Reiss, A. Schatzberg, H. Solvason, 2008, The American journal of psychiatry.

Psychotic and nonpsychotic depressions: I. comparisons of plasma catecholamines and cortisol measures

A. Schatzberg, P. Langlais, A. Rothschild, 1987, Psychiatry Research.

Diagnosis of affective disorders in the elderly.

A. Schatzberg, A. Satlin, B. Liptzin, 1984, Psychosomatics.

Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis

A. Young, C. Pariante, A. Schatzberg, 2019, Psychoneuroendocrinology.

Delusional depression, family history, and DST response: A pilot study

T. C. Bond, A. Schatzberg, A. Rothschild, 1986, Biological Psychiatry.

Postdexamethasone cortisol levels and subgroups of affective illness.

A. Schatzberg, A. Rothschild, 1985, Archives of general psychiatry.

BIOCHEMICAL DISCRIMINATION OF SUBGROUPS OF DEPRESSIVE DISORDERS BASED ON DIFFERENCES IN CATECHOLAMINE METABOLISM

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1982 .

Platelet MAO activity and the dexamethasone suppression test in depressed patients.

A. Schatzberg, J. Schildkraut, A. Rothschild, 1983, The American journal of psychiatry.

Dexamethasone increases plasma free dopamine in man.

A. Schatzberg, E. Bird, P. Langlais, 1984, Journal of psychiatric research.

Genetic Variation in Corticotropin Releasing Hormone Binding Protein predicts antidepressant outcomes

L. Williams, C. Nemeroff, A. Schatzberg, 2018 .

Pharmacological treatments for unipolar depression.

C. Nemeroff, A. Schatzberg, 2007 .

A word to the wise about ketamine.

A. Schatzberg, 2014, The American journal of psychiatry.

Toward a Biochemical Classification of Depressive Disorders IX

A. Schatzberg, J. Schildkraut, Benjamin Gerson, 1985, British Journal of Psychiatry.

Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

A. Schatzberg, G. Sanacora, 2015, Neuropsychopharmacology.

More Thoughts on Intranasal Esketamine: Response to Drevets et al.

A. Schatzberg, 2019, The American journal of psychiatry.

Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect.

A. Schatzberg, N. Williams, B. Bentzley, 2019, JAMA psychiatry.

Cortisol feedback during the HPA quiescent period in patients with major depression.

A. Schatzberg, J. Posener, G. Williams, 2001, The American journal of psychiatry.

subtypes of psychotic patients. The dexamethasone suppression test as a discriminator among

A. Schatzberg, A. Rothschild, A. Rosenbaum, 2013 .

A Randomized Trial of the Efficacy of Group Therapy in Changing Viral Load and CD4 Counts in Individuals Living with HIV Infection

C. Koopman, A. Schatzberg, D. Spiegel, 2005, International journal of psychiatry in medicine.

Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

M. Fava, M. Trivedi, A. Schatzberg, 2019, Molecular Psychiatry.

Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE ε4 carriers

J. Yesavage, A. Schatzberg, R. O'Hara, 2005, Neurology.

Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.

H. Kraemer, J. Yesavage, A. Schatzberg, 2005, Neurology.

Recent Studies on Selective Serotonergic Antidepressants

A. Schatzberg, D. Katz, J. Cole, 1987 .

Recent Studies on Selective Serotonergic Antidepressants: Trazodone, Fluoxetine, and Fluvoxamine

A. Schatzberg, D. Katz, P. O'Neil, 1987, Journal of clinical psychopharmacology.

Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.

A. Young, A. Schatzberg, J. Zajecka, 1997, The Journal of clinical psychiatry.

Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.

A. Schatzberg, J. Schildkraut, P. Orsulak, 1978, Biological psychiatry.

Elevated platelet MAO activity in schizophrenia-related depressive disorders.

A. Schatzberg, J. Schildkraut, P. Orsulak, 1978, The American journal of psychiatry.

Hypomania and mania after withdrawal of tricyclic antidepressants.

A. Schatzberg, S. Mirin, D. Creasey, 1981, The American journal of psychiatry.

Effects of Short- and Long-Term Administration of Tricyclic Antidepressants and Lithium on Norepinephrine Turnover in Brain*

A. Schatzberg, J. Schildkraut, M. Kling, 1976, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.

A. Schatzberg, L. Mccurdy, 1978, The Journal of clinical psychiatry.

New indications for antidepressants.

A. Schatzberg, 2000, The Journal of clinical psychiatry.

Early- versus late-onset dythymic disorder: comparison in out-patients with superimposed major depressive episodes.

J. Markowitz, M. Keller, A. Schatzberg, 1999, Journal of affective disorders.

Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al.

A. Schatzberg, N. Williams, B. Bentzley, 2021, Molecular Psychiatry.

ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.

L. Lazzeroni, L. Williams, A. Etkin, 2015, The American journal of psychiatry.

Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.

A. Schatzberg, J. Schildkraut, R. LaBrie, 1978, Archives of general psychiatry.

Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.

A. Schatzberg, J. Cole, 1981, British journal of clinical pharmacology.

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis.

A. Schatzberg, C. Blasey, S. Fleming, 2004, Journal of psychiatric research.

Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination

J. Markowitz, A. Rush, M. Trivedi, 2002, Biological Psychiatry.

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

J. Markowitz, A. Rush, M. Thase, 1998, The Journal of clinical psychiatry.

Social functioning in depression: a review.

M B Keller, S Kasper, H. Möller, 2000, The Journal of clinical psychiatry.

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

J. Lieberman, J. Markowitz, S. Kanba, 2007, The international journal of neuropsychopharmacology.

The American Psychiatric Publishing textbook of mood disorders

D. Kupfer, D. Stein, A. Schatzberg, 2006 .

BENZODIAZEPINES IN THE TREATMENT OF DEPRESSIVE,

A. Schatzberg, J. Cole, 2006 .

Commentary on Abortion Studies of Steinberg and Finer (Social Science & Medicine 2011; 72:72–82) and Coleman (Journal of Psychiatric Research 2009;43:770–6 & Journal of Psychiatric Research 2011;45:1133–4)

R. Kessler, A. Schatzberg, 2012 .

Foreword

A. Schatzberg, 2006, Biological Psychiatry.

Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.

A. Schatzberg, J. Schildkraut, K. Bloomingdale, 1989, Archives of general psychiatry.

The Black Book of Psychotropic Dosing and Monitoring.

A. Schatzberg, DeBattista Charles, 2018, Psychopharmacology bulletin.

Diagnosis and Treatment of Psychotic (Delusional) Depression

A. Schatzberg, A. Rothschild, 1994 .

Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression

T. C. Bond, A. Schatzberg, J. Schildkraut, 1993, Biological Psychiatry.

Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

A. Schatzberg, A. Rothschild, 1992, The American journal of psychiatry.

Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function

A. Schatzberg, J. Keller, J. Posener, 2009, Psychoneuroendocrinology.

The Neuropsychological Profile of Psychotic Major Depression and its Relation to Cortisol

A. Schatzberg, Benjamin H. Flores, H. Kenna, 2006, Biological Psychiatry.

HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition

A. Schatzberg, J. Keller, K. Cherian, 2019, Schizophrenia Research.

Corrigendum to: Glucocorticoid antagonists in neuropsychiatric disorders [European Journal of Pharmacology 583 (2008) 358–364]

A. Schatzberg, S. Lindley, 2008 .

Glucocorticoid antagonists in neuropsychiatric [corrected] disorders.

A. Schatzberg, S. Lindley, 2008, European journal of pharmacology.

Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain.

D. M. Lyons, A. Schatzberg, J. F. Lopez, 2000, Journal of psychiatric research.

Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study.

A. Schatzberg, J. Posener, C. Debattista, 2000, The American journal of psychiatry.

Stress-Level Cortisol Treatment Impairs Inhibitory Control of Behavior in Monkeys

D. M. Lyons, A. Schatzberg, A F Schatzberg, 2000, The Journal of Neuroscience.

Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.

A. Schatzberg, H. Solvason, C. Debattista, 2000, Journal of clinical psychopharmacology.

Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex.

R. Myers, S. Potkin, T. V. van Erp, 2013, Journal of psychiatric research.

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

A. Schatzberg, S. Brannan, C. Mallinckrodt, 2005, Journal of psychiatric research.

A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia

Turan M. Itil, Alan F. Schatzberg, A. Schatzberg, 1997 .

Mild early life stress enhances prefrontal-dependent response inhibition in monkeys

K. J. Parker, D. M. Lyons, A. Schatzberg, 2005, Biological Psychiatry.

Neuroendocrine aspects of hypercortisolism in major depression

K. J. Parker, D. M. Lyons, A. Schatzberg, 2003, Hormones and Behavior.

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

D. M. Lyons, A. Schatzberg, C. Rodriguez, 2018, The American journal of psychiatry.

Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response.

J. Markowitz, M. Thase, M. Keller, 1999, Journal of affective disorders.

Toward a biochemical classification of depressive disorders

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1981, Psychopharmacology.

Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression

Robert C. Thompson, R. Myers, H. Akil, 2010, Molecular Psychiatry.

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma

B. Rothbaum, A. Rush, M. Thase, 2003, Proceedings of the National Academy of Sciences of the United States of America.

A corticosteroid/dopamine hypothesis for psychotic depression and related states.

A. Schatzberg, E. Bird, P. Langlais, 1985, Journal of psychiatric research.

Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders

L. DeLisi, R. Myers, H. Akil, 2016, Microarrays.

Separation induced changes in squirrel monkey hypothalamic-pituitary-adrenal physiology resemble aspects of hypercortisolism in humans

D. M. Lyons, N. Kalin, A. Schatzberg, 1999, Psychoneuroendocrinology.

Relationships between brain ct scan findings and cortisol in psychotic and nonpsychotic depressed patients

B. Woods, F. Benes, A. Schatzberg, 1989, Biological Psychiatry.

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

A. Schatzberg, T. Itil, A. Freedman, 1997, JAMA.

Gender differences in treatment response to sertraline versus imipramine in chronic depression.

M. Thase, S. Davis, M. Keller, 2000, The American journal of psychiatry.

Maprotiline treatment in depression. A perspective on seizures.

B. Woods, A. Schatzberg, J. Cole, 1986, Archives of general psychiatry.

Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5‐A3‐B4) predict severity of nicotine addiction and response to smoking cessation therapy

L. Lazzeroni, A. Schatzberg, S. Fortmann, 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy.

A. Schatzberg, S. Fortmann, J. Killen, 2010, Addiction.

Extended treatment with bupropion SR for cigarette smoking cessation.

A. Schatzberg, S. Fortmann, J. Killen, 2006, Journal of consulting and clinical psychology.

Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways

Laura J. Scott, Naomi R. Wray, Margaret A. Pericak-Vance, 2015, Nature Neuroscience.

Essentials of Clinical Psychopharmacology

C. Nemeroff, A. Schatzberg, 2001 .

The genetics of the mood disorder spectrum: genome-wide association analyses of over 185,000 cases and 439,000 controls

Melissa J. Green, Robert C. Thompson, Pamela B. Mahon, 2018, bioRxiv.

Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder

Melissa J. Green, Robert C. Thompson, Pamela B. Mahon, 2017, bioRxiv.

From Clinical Research to Clinical Practice: A 4-Year Review of Ziprasidone

Philip D. Harvey, J. Lieberman, C. Kilts, 2005, CNS Spectrums.

G protein-linked signaling pathways in bipolar and major depressive disorders

Mary E. Ziegler, R. Myers, Jun Z. Li, 2013, Front. Genet..

Identification of potential blood biomarkers associated with suicide in major depressive disorder

H. Akil, A. Schatzberg, W. Bunney, 2022, Translational Psychiatry.

Mitochondrial Mutations in Subjects with Psychiatric Disorders

P. Baldi, R. Myers, H. Akil, 2015, PloS one.

Quantitative Trait Locus and Brain Expression of HLA-DPA1 Offers Evidence of Shared Immune Alterations in Psychiatric Disorders

L. DeLisi, R. Myers, H. Akil, 2016, Microarrays.

The Roles of Glucocorticoid and Dopaminergic Systems in Delusional (Psychotic) Depression a

A. Schatzberg, A. Rothschild, 1988, Annals of the New York Academy of Sciences.

Mechanisms of Action of Ketamine and Esketamine.

A. Schatzberg, 2021, The American journal of psychiatry.

A Concise Guide to Understanding Suicide: Anxiety, depression, and suicide: epidemiology, pathophysiology, and prevention

A. Schatzberg, Giampaolo Robert Perna, 2014 .

Gene Expression Changes in the Prefrontal Cortex, Anterior Cingulate Cortex and Nucleus Accumbens of Mood Disorders Subjects That Committed Suicide

R. Myers, Jun Z. Li, H. Akil, 2012, PloS one.

Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

A. Schatzberg, Benjamin H. Flores, H. Solvason, 2006, Neuropsychopharmacology.

An open label trial of C-1073 (mifepristone) for psychotic major depression*

A. Schatzberg, E. Baulieu, F. Cassidy, 2002, Biological Psychiatry.

Rapid Reversal of Psychotic Depression Using Mifepristone

Alan F. Schatzberg, A. Schatzberg, Benjamin H. Flores, 2001, Journal of clinical psychopharmacology.

Psychopharmacological screening criteria. APA Committee on Research on Psychiatric Treatments.

H. Pincus, A. Schatzberg, J. Kane, 1992, The Journal of clinical psychiatry.

Premenstrual exacerbation of depression

A. Schatzberg, S. Kornstein, K. Yonkers, 1995 .

Gabapentin and Pregabalin

M. Frye, A. Schatzberg, K. Moore, 2009 .

Post-mortem molecular profiling of three psychiatric disorders

Stanley J. Watson, Huda Akil, Kevin M. Bowling, 2016, Genome Medicine.

Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder

R. Myers, Jun Z. Li, H. Akil, 2014, Molecular Psychiatry.

Neurobiologic Foundations of Mood Disorders

A. Schatzberg, R. Duman, H. Polan, 2015 .

Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder

R. Myers, S. Potkin, H. Akil, 2015, Translational Psychiatry.

A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.

A. Schatzberg, S. Roose, 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.

A. Schatzberg, G. Murphy, H. Rodrigues, 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The Career Development Institute for Psychiatry: An Innovative, Longitudinal Program for Physician-Scientists

D. Kupfer, A. Schatzberg, R. O'Hara, 2009, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

Recruiting and retaining future generations of physician scientists in mental health.

D. Kupfer, S. Hyman, C. Reynolds, 2002, Archives of general psychiatry.

Issues encountered in recent attempts to develop novel antidepressant agents

A. Schatzberg, 2015, Annals of the New York Academy of Sciences.

Using chronic pain to predict depressive morbidity in the general population.

Maurice M Ohayon, A. Schatzberg, M. Ohayon, 2003, Archives of general psychiatry.

Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

R. Myers, H. Akil, A. Schatzberg, 2009, PloS one.

Stress amplifies sex differences in primate prefrontal profiles of gene expression

Stanley J. Watson, Huda Akil, D. M. Lyons, 2017, Biology of Sex Differences.

Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis

Huda Akil, Richard M Myers, Marquis P Vawter, 2018, PloS one.

Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression

N. Kalin, A. Schatzberg, Thaddeus S Block, 2017, Journal of clinical psychopharmacology.

On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders.

A. Schatzberg, T. Buckley, 2005, The Journal of clinical endocrinology and metabolism.

Mitochondrial involvement in psychiatric disorders

R. Myers, H. Akil, A. Schatzberg, 2008, Annals of medicine.

Pharmacotherapy of depression and mixed states in bipolar disorder.

J. Guelfi, C. Nemeroff, A. Schatzberg, 2000, Journal of affective disorders.

Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.

K. J. Parker, A. Schatzberg, H. Kenna, 2014, Journal of psychiatric research.

Relating semantic and episodic memory systems.

Vinod Menon, Allan L Reiss, V. Menon, 2002, Brain research. Cognitive brain research.

Pharmacogenetics of antidepressant medication intolerance.

A. Schatzberg, G. Murphy, Greer M Murphy, 2003, The American journal of psychiatry.

Clozapine in the treatment of refractory psychotic mania.

M. D. Banov, M. Tohen, A. Schatzberg, 2000, The American journal of psychiatry.

Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response

N. Kalin, A. Schatzberg, Thaddeus S Block, 2018, Biological Psychiatry.

Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression

A. Schatzberg, I. Gotlib, J. Keller, 2018, Translational Psychiatry.

Manual of Clinical Psychopharmacology, Seventh Edition

A. Schatzberg, C. Debattista, J. Cole, 2010 .

The future of psychiatry as clinical neuroscience.

D. A. Lewis, D. Kupfer, C. Reynolds, 2009, Academic medicine : journal of the Association of American Medical Colleges.

Intranasal oxytocin administration attenuates the ACTH stress response in monkeys

K. J. Parker, D. M. Lyons, Karen J. Parker, 2005, Psychoneuroendocrinology.

The American Psychiatric Publishing Textbook of Psychopharmacology

C. Nemeroff, A. Schatzberg, 2009 .

Manual of clinical psychopharmacology

A. Schatzberg, C. Debattista, 1991 .

Chapter 28 – Psychiatric Disorders

A. Schatzberg, 2017 .

Chapter 31 – Psychiatric Disorders

A. Schatzberg, Kenneth T. Norris, 2009 .

Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.

Donna M. Palmer, L. Williams, A. Etkin, 2015, The American journal of psychiatry.

Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population

Marquis P. Vawter, L. DeLisi, R. Myers, 2011, Schizophrenia Research.

Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.

A. Schatzberg, J. Schildkraut, J. Samson, 1982, The American journal of psychiatry.

Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

H. Kraemer, D. Kupfer, M. Fava, 2006, Neuropsychopharmacology.

Norepinephrine Metabolism in Depressive Disorders: Implications for a Biochemical Classification of Depressions

A. Schatzberg, J. Schildkraut, R. LaBrie, 1978 .

McLean Hospital Depression Research Facility: early-onset phobic disorders and adult-onset major depression

T. C. Bond, A. Schatzberg, D. Regier, 1998, British Journal of Psychiatry.

Preliminary evidence that plasma oxytocin levels are elevated in major depression

K. J. Parker, A. Schatzberg, H. Kenna, 2010, Psychiatry Research.

Expression patterns of corticotropin‐releasing factor, arginine vasopressin, histidine decarboxylase, melanin‐concentrating hormone, and orexin genes in the human hypothalamus

H. Akil, A. Schatzberg, W. Bunney, 2010, The Journal of comparative neurology.

Slowing the progression of cognitive decline in alzheimer’s disease using mifepristone

A. Schatzberg, J. Belanoff, C. Debattista, 2002, Journal of Molecular Neuroscience.

Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol

H. Kraemer, A. Schatzberg, M. Weiner, 2007, Molecular Psychiatry.

Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation.

A. Schatzberg, Alan F Schatzberg, Theresa M Buckley, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Cognitive Correlates of White Matter Growth and Stress Hormones in Female Squirrel Monkey Adults

D. M. Lyons, A. Reiss, A. Schatzberg, 2004, The Journal of Neuroscience.

Anna-Monika Award Lecture, DGPPN Kongress, 2013: The role of the hypothalamic–pituitary–adrenal (HPA) axis in the pathogenesis of psychotic major depression

A. Schatzberg, 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Dexamethasone elevates dopamine in human plasma and rat brain.

A. Schatzberg, E. Bird, P. Langlais, 1984, Psychopharmacology bulletin.

ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression

M. Trivedi, L. Lazzeroni, A. Ray, 2014, The Pharmacogenomics Journal.

The American Psychiatric Association Publishing Textbook of Psychopharmacology

C. Nemeroff, A. Schatzberg, 2017 .

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.

Alan J Gelenberg, Anthony J Rothschild, James M Ferguson, 2007, The Journal of clinical psychiatry.

Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.

M. Thase, M. Keller, A. Schatzberg, 1998, JAMA.

New approaches to managing psychotic depression.

A. Schatzberg, 2003, The Journal of clinical psychiatry.

Antidepressant effectiveness in severe depression and melancholia.

A. Schatzberg, 1999, The Journal of clinical psychiatry.

Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs

A. Schatzberg, M. Sofuoglu, C. Debattista, 1998, Biological Psychiatry.

Physical symptoms associated with paroxetine withdrawal.

A. Schatzberg, C. Debattista, 1995, The American journal of psychiatry.

A Prospective Trial of Bupropion SR Augmentation of Partial and Non-Responders to Serotonergic Antidepressants

A. Schatzberg, H. Solvason, C. Debattista, 2003, Journal of clinical psychopharmacology.

Stress coping stimulates hippocampal neurogenesis in adult monkeys

D. M. Lyons, A. Schatzberg, R. Mitra, 2010, Proceedings of the National Academy of Sciences.

Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression

H. Kraemer, A. Schatzberg, 2000, Biological Psychiatry.

Phenomenology and treatment of agitation.

A. Schatzberg, C. Debattista, 1999, The Journal of clinical psychiatry.

Valproate in the Treatment of Agitation Associated with Depression

A. Schatzberg, C. Debattista, S. DeGolia, 1996 .

Psychotropic dosing and monitoring guidelines

A. Schatzberg, C. Debattista, 2006 .

Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.

A. Schatzberg, Jieling Chen, R. Mallick, 2003, The Journal of clinical psychiatry.

Dosing strategies for antidepressant agents.

A. Schatzberg, 1991, The Journal of clinical psychiatry.

Fluoxetine and desipramine in major depressive disorder.

A. Schatzberg, C. Bowden, J. Samson, 1993, Journal of clinical psychopharmacology.

The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.

J. Markowitz, A. Rush, M. Thase, 1998, The Journal of clinical psychiatry.

DEPRESSION : Mind and Body Advances in the Understanding and Treatment of Depression and its Physical Symptoms Biological and Psychosocial Correlates of Perimenopausal Depression : Implications for Treatment

M. Fava, M. Trivedi, A. Schatzberg, 2007 .

Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.

L. Williams, A. Etkin, A. Schatzberg, 2015, Journal of affective disorders.

The American Psychiatric Press Textbook of Psychopharmacology

C. Nemeroff, A. Schatzberg, 1995 .

Post-mortem molecular profiling of three psychiatric disorders

Brittany N. Lasseigne, R. Myers, Jun Z. Li, 2016, bioRxiv.

Employing pharmacologic treatment of bipolar disorder to greatest effect.

A. Schatzberg, 2004, The Journal of clinical psychiatry.

Royalty/patent, other income: Patents for Sequential Parallel Comparison Design (SPCD), licensed by MGH to Pharmaceutical Product Development, LLC (PPD) (US_7840419, US_7647235, US_7983936, US_8145504, US_8145505); and patent application for a combination of Ketamine plus Scopolamine in Major Depres

M. Fava, M. Trivedi, A. Schatzberg, 2019 .

Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration and adrenalectomy in Fischer 344 and Lewis rats

A. Schatzberg, D. L. Wong, T. Bengoechea, 2002, Brain Research.

Glucocorticoid Effects on Mesotelencephalic Dopamine Neurotransmission

A. Schatzberg, D. L. Wong, T. Bengoechea, 1999, Neuropsychopharmacology.

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

D. M. Lyons, A. Schatzberg, K. Sudheimer, 2019, Molecular Psychiatry.

The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.

Robert C. Thompson, R. Myers, H. Akil, 2016, Journal of psychiatric research.

Altered choroid plexus gene expression in major depressive disorder

Robert C. Thompson, R. Myers, H. Akil, 2014, Front. Hum. Neurosci..

Preliminary Evidence That Hippocampal Volumes in Monkeys Predict Stress Levels of Adrenocorticotropic Hormone

K. J. Parker, Jamie M. Zeitzer, D. M. Lyons, 2007, Biological Psychiatry.

reliminary Evidence That Hippocampal Volumes n Monkeys Predict Stress Levels of drenocorticotropic Hormone

K. J. Parker, A. Schatzberg, J. Zeitzer, 2007 .

Evidence for alterations of the glial syncytial function in major depressive disorder.

Robert C. Thompson, R. Myers, H. Akil, 2016, Journal of psychiatric research.

Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial

S. Wisniewski, E. Gordon, L. Williams, 2013, Trials.

Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research.

R. Shelton, M. Fava, A. Schatzberg, 2006, The Journal of clinical psychiatry.

Ecological validity of social defeat stressors in mouse models of vulnerability and resilience

D. M. Lyons, A. Schatzberg, M. Müller, 2023, Neuroscience & Biobehavioral Reviews.

SLEEP AND WAKEFULNESS

A. Schatzberg, R. Pelayo, 2007 .

NMDA antagonist treatment of depression

A. Schatzberg, N. Williams, 2016, Current Opinion in Neurobiology.

Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response

C. Nemeroff, A. Schatzberg, T. Schlaepfer, 2011, Psychological Medicine.

Recent Studies of the Biology and Treatment of Depression

A. Schatzberg, 2005 .

Decoding the temporal nature of brain GR activity in the NFκB signal transition leading to depressive-like behavior

D. M. Lyons, A. Schatzberg, J. Seo, 2021, Molecular Psychiatry.

Excessive Sleepiness : Determinants , Outcomes , 141 and Context

D. Kupfer, N. Kalin, A. Schatzberg, 2008 .

Wilhelm Reich: self-destined victim and social casualty. A study of his trial and appeal.

A. Schatzberg, 1972, Archives of general psychiatry.

National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.

D. Kupfer, N. Kalin, K. Krishnan, 2002, Archives of general psychiatry.

Prevalence, Factor Structure, and Heritability of Avoidant Personality Disorder

A. Schatzberg, J. Reich, 2021, The Journal of nervous and mental disease.

Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates.

K. J. Parker, D. M. Lyons, A. Schatzberg, 2006, Proceedings of the National Academy of Sciences of the United States of America.

The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.

Donna M. Palmer, E. Gordon, L. Williams, 2015, Journal of psychiatric research.

Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.

M. Thase, M. Keller, A. Schatzberg, 2002, Archives of general psychiatry.

24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression.

A. Schatzberg, J. Posener, G. Williams, 2000, Archives of general psychiatry.

Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1982, The American journal of psychiatry.

Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?

A. Schatzberg, 2022, The American journal of psychiatry.

Hypothalamic–pituitary–adrenal axis effects on plasma homovanillic acid in man

A. Schatzberg, J. Schildkraut, J. Posener, 1999, Biological Psychiatry.

Onset of major depression during treatment for nicotine dependence.

A. Schatzberg, S. Fortmann, J. Killen, 2003, Addictive behaviors.

24 Efficacy of Nefazodone in Chronic Depression.

M. Keller, A. Schatzberg, Maureen R. Prather, 2002 .

Clinical use of nefazodone in major depression: a 6-year perspective.

A. Rush, M. Keller, A. Schatzberg, 2002, The Journal of clinical psychiatry.

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

L. Williams, C. Nemeroff, A. Schatzberg, 2017, The American journal of psychiatry.

REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.

M. Trivedi, M. Thase, S. Wisniewski, 2008, Psychopharmacology bulletin.

Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trial

L. Williams, A. Schatzberg, Adina S. Fischer, 2020, Neuropsychopharmacology.

Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression

Conor Liston, Alvaro Pascual-Leone, Helen S Mayberg, 2017, Nature Medicine.

Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) Induces Functional Connectivity Changes in Emotion Regulation Brain Areas for MDD Patients

A. Schatzberg, K. Sudheimer, K. Stimpson, 2019 .

Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders.

A. Schatzberg, N. Rasgon, T. Wroolie, 2018, Journal of affective disorders.

Gender differences in chronic major and double depression.

M. Thase, S. Davis, M. Keller, 2000, Journal of affective disorders.

ild Early Life Stress Enhances Prefrontal-Dependent esponse Inhibition in Monkeys

D. M. Lyons, A. Schatzberg, Christine L. Buckmaster, 2005 .

Prospective investigation of stress inoculation in young monkeys.

K. J. Parker, D. M. Lyons, A. Schatzberg, 2004, Archives of general psychiatry.

Neural cell adhesion molecule peptide mimetics modulate emotionality: pharmacokinetic and behavioral studies in rats and non-human primates

D. M. Lyons, H. Akil, A. Schatzberg, 2018, Neuropsychopharmacology.

Prefrontal Plasticity and Stress Inoculation-Induced Resilience

K. J. Parker, D. M. Lyons, M. Moseley, 2009, Developmental Neuroscience.

Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder.

R. Myers, H. Akil, A. Schatzberg, 2013, Journal of psychiatric research.

BENZODIAZEPINES INTHETREATMENTOFDEPRESSIVE, BORDERLINE PERSONALITY, ANDSCHIZOPHRENIC DISORDERS

A. Schatzberg, J. Cole, 1981 .

Evidence for Transcriptional Factor Dysregulation in the Dorsal Raphe Nucleus of Patients with Major Depressive Disorder

Robert C. Thompson, R. Myers, H. Akil, 2012, Front. Neurosci..

Which antidepressants have demonstrated superior efficacy? A review of the evidence

Naomi A. Fineberg, Hans-Jürgen Möller, Siegfried Kasper, 2007, International clinical psychopharmacology.

Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.

J. Markowitz, B. Rothbaum, A. Rush, 2005, Archives of general psychiatry.

Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia

H. Akil, A. Schatzberg, W. Bunney, 2023, Translational Psychiatry.

Sertraline versus imipramine to prevent relapse in chronic depression.

M. Thase, M. Keller, A. Schatzberg, 2001, Journal of affective disorders.

Depression in the elderly.

A. Schatzberg, W. McDonald, C. Salzman, 2002, Psychopharmacology bulletin.

Decreased Hypothalamic Functional Connectivity with Subgenual Cortex in Psychotic Major Depression

A. Reiss, A. Schatzberg, H. Kenna, 2015, Neuropsychopharmacology.

Long-term effects of intermittent early life stress on primate prefrontal–subcortical functional connectivity

K. J. Parker, D. M. Lyons, V. Menon, 2021, Neuropsychopharmacology.

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

A. Schatzberg, J. Posener, P. Shear, 2000, The American journal of psychiatry.

Chronic pain and major depressive disorder in the general population.

A. Schatzberg, M. Ohayon, 2010, Journal of psychiatric research.

Cognitive and Noncognitive Symptoms in Dementia Patients: Relationship to Cortisol and Dehydroepiandrosterone

J. Yesavage, A. Schatzberg, J. Tinklenberg, 1998, International Psychogeriatrics.

In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment.

H. Kraemer, J. Lieberman, A. Schatzberg, 2009, Journal of psychiatric research.

Prevalence of depressive episodes with psychotic features in the general population.

A. Schatzberg, M. Ohayon, 2002, The American journal of psychiatry.

Anxiety and adjustment disorder: a treatment approach.

A. Schatzberg, 1990, The Journal of clinical psychiatry.

Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder.

Robert C. Thompson, R. Myers, H. Akil, 2013, Journal of psychiatric research.

Multisensory modulation of body ownership in mice

D. M. Lyons, A. Schatzberg, L. de Lecea, 2020, Neuroscience of consciousness.

A pilot study of the phase angle between cortisol and melatonin in major depression - a potential biomarker?

A. Schatzberg, T. Buckley, 2010, Journal of psychiatric research.

Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants

T. Hastie, L. Williams, C. Nemeroff, 2016, Proceedings of the National Academy of Sciences.

Animal models of early life stress: Implications for understanding resilience.

K. J. Parker, D. M. Lyons, A. Schatzberg, 2010, Developmental psychobiology.

Cortisol activity and cognitive changes in psychotic major depression.

A. Schatzberg, J. Belanoff, B. Sund, 2001, The American journal of psychiatry.

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study

Sarah H. Lisanby, Andrew Krystal, William W. McDonald, 2010, Brain Stimulation.

Insular cortex abnormalities in psychotic major depression: Relationship to gender and psychotic symptoms

Jeremy D. Cohen, A. Reiss, A. Schatzberg, 2013, Neuroscience Research.

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression

L. Lazzeroni, A. Schatzberg, H. Ryan, 2010, Pharmacogenetics and genomics.

Aberrant brain activation during a working memory task in psychotic major depression.

Allan L Reiss, A. Reiss, A. Schatzberg, 2011, The American journal of psychiatry.

Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression

Jeremy D. Cohen, A. Reiss, A. Schatzberg, 2013, Psychiatry Research: Neuroimaging.

FKBP5 polymorphisms and antidepressant response in geriatric depression

L. Lazzeroni, A. Schatzberg, H. Ryan, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Cortisol Circadian Rhythm Alterations in Psychotic Major Depression

A. Schatzberg, Benjamin H. Flores, H. Solvason, 2006, Biological Psychiatry.

The Efficacy of Antidepressants in the Treatment of Late-Life Depression

A. Schatzberg, S. Roose, 2005, Journal of clinical psychopharmacology.

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

A. Schatzberg, G. Murphy, H. Rodrigues, 2004, Archives of general psychiatry.

The apolipoprotein E ε4 allele and antidepressant efficacy in cognitively intact elderly depressed patients

A. Schatzberg, G. Murphy, H. Rodrigues, 2003, Biological Psychiatry.

The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary–adrenal activity in humans with psychotic major depression

A. Schatzberg, J. Keller, F. Kraemer, 2013, Psychoneuroendocrinology.

Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.

J. Markowitz, A. Rush, M. Trivedi, 2002, The Journal of clinical psychiatry.

Personalizing antidepressant choice by sex, body mass index, and symptom profile: An iSPOT-D report

Jun Ma, A. Schatzberg, A. Goldstein-Piekarski, 2017 .

The chicken and egg of anxiety and depression

A. Schatzberg, 2015, Epidemiology and Psychiatric Sciences.

Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report.

L. Williams, A. Etkin, A. Schatzberg, 2015, Journal of affective disorders.

Can Target Engagement Studies Miss Their Targets and Mislead Drug Development?

A. Schatzberg, 2021, American Journal of Psychiatry.

Stress-induced changes in primate prefrontal profiles of gene expression

D. M. Lyons, R. Myers, H. Akil, 2007, Molecular Psychiatry.

Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.

A. Schatzberg, 2003, The Journal of clinical psychiatry.

Acute and delayed effects of adrenocorticotropic hormone on dopamine activity in man

A. Schatzberg, J. Schildkraut, J. Posener, 1994 .

Early Environmental Regulation of Glucocorticoid Feedback Sensitivity in Young Adult Monkeys

D. M. Lyons, A. Schatzberg, C. Yang, 2000, Journal of neuroendocrinology.

Postnatal Experiences and Genetic Effects on Squirrel Monkey Social Affinities and Emotional Distress

D. M. Lyons, N. Risch, A. Schatzberg, 1999, Hormones and Behavior.

Antidepressant early response and remission of venlafaxine and fluoxetine in geriatric outpatients

A. Schatzberg, M. Cantillon, 2000, European Neuropsychopharmacology.

Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man

A. Schatzberg, J. Schildkraut, J. Posener, 1994, Biological Psychiatry.

Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression.

A. Schatzberg, 2019, The American journal of psychiatry.

Cortisol feedback effects on plasma corticotropin levels in healthy subjects

A. Schatzberg, J. Schildkraut, J. Posener, 1997, Psychoneuroendocrinology.

HPA axis activation in major depression and response to fluoxetine: a pilot study

A. Schatzberg, E. Young, J. Zubieta, 2004, Psychoneuroendocrinology.

Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.

S. Davis, A. Schatzberg, D. Klein, 2002, Archives of general psychiatry.

Trazodone: a 5-year review of antidepressant efficacy.

A. Schatzberg, 1987, Psychopathology.

Methodes de traitement de la psychose associee a un dysfonctionnement lie aux glucocorticoides

A. Schatzberg, J. Belanoff, 1998 .

Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research

D. A. Lewis, B. Turetsky, F. McMahon, 2016, Biological Psychiatry.

Empirical evidence of the effect of personality pathology on the outcome of panic disorder.

A. Schatzberg, K. Delucchi, J. Reich, 2018, Journal of psychiatric research.

Learning to actively cope with stress in female mice

D. M. Lyons, A. Schatzberg, Christine L. Buckmaster, 2018, Psychoneuroendocrinology.

Resilience as a process instead of a trait

D. M. Lyons, A. Schatzberg, 2020 .

Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.

A. Schatzberg, J. Schildkraut, J. Samson, 1985, Journal of psychiatric research.

Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.

J. Amsterdam, A. Nierenberg, A. Schatzberg, 2007, The Journal of clinical psychiatry.

The unique impact of late-life bereavement and prolonged grief on diurnal cortisol.

A. Schatzberg, R. O'Hara, Vincent Rozalski, 2014, The journals of gerontology. Series B, Psychological sciences and social sciences.

Nonlinear relationship between early life stress exposure and subsequent resilience in monkeys

K. J. Parker, D. M. Lyons, A. Schatzberg, 2019, Scientific Reports.

mtDNA copy number, mtDNA total somatic deletions, Complex I activity, synapse number and synaptic mitochondria number are altered in schizophrenia and bipolar disorder

R. Myers, H. Akil, A. Schatzberg, 2022, medRxiv.

Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder

J. Amsterdam, A. Nierenberg, A. Schatzberg, 2009, Neuropsychobiology.

Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy

A. Schatzberg, R. O'Hara, J. Holland, 2013, Psychiatry Research.

The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic–adrenal–pituitary (HPA) axis activity in healthy controls

A. Schatzberg, T. Buckley, Blair C. Mullen, 2007, Psychoneuroendocrinology.

Coping and glucocorticoid receptor regulation by stress inoculation

D. M. Lyons, A. Schatzberg, Alex G. Lee, 2014, Psychoneuroendocrinology.

Developmental Cascades Linking Stress Inoculation, Arousal Regulation, and Resilience

K. J. Parker, D. M. Lyons, Karen J. Parker, 2009, Front. Behav. Neurosci..

Animal models of early life stress: implications for understanding resilience.

K. J. Parker, D. M. Lyons, A. Schatzberg, 2010, Developmental psychobiology.

Early life stress and novelty seeking behavior in adolescent monkeys

K. J. Parker, D. M. Lyons, A. Schatzberg, 2007, Psychoneuroendocrinology.

Postnatal foraging demands alter adrenocortical activity and psychosocial development.

D. M. Lyons, A. Schatzberg, S. Levine, 1998, Developmental psychobiology.

Hypothalamic-pituitary-adrenal axis physiology and cognitive control of behavior in stress inoculated monkeys

K. J. Parker, D. M. Lyons, A. Schatzberg, 2012, International journal of behavioral development.

Pharmacological principles of antidepressant efficacy

A. Schatzberg, 2002, Human psychopharmacology.

Annual Conference of the Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP). Sleepless Mind. Mindless Sleep? Bern, March 25 and 26, 2009

T. Hansen, K. D. Jakobsen, J. Amsterdam, 2009, Neuropsychobiology.

A Cognitive Biotype of Depression and Symptoms, Behavior Measures, Neural Circuits, and Differential Treatment Outcomes

A. Schatzberg, L. Tozzi, M. Korgaonkar, 2023, JAMA network open.

Reply: Clinical and Biological Effects of Mifepristone Treatment for Psychotic Treatment

A. Schatzberg, J. Keller, 2006, Neuropsychopharmacology.

Developing novel treatments for mood disorders: accelerating discovery

K. Davis, T. Suppes, E. Sausville, 2002, Biological Psychiatry.

Detecting psychotic major depression using psychiatric rating scales.

A. Schatzberg, Benjamin H. Flores, H. Kenna, 2006, Journal of psychiatric research.

Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat.

A. Schatzberg, J. Ballenger, 1991, The Journal of clinical psychiatry.

Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.

A. Schatzberg, A. Montejo, D. Desaiah, 2009, Journal of psychiatric research.

BIOCHEMICAL DISCRIMINATION OF SUBTYPES OF DEPRESSIVE DISORDERS

A. Schatzberg, J. Schildkraut, R. LaBrie, 1979 .

MHPG as a predictor of antidepressant response to imipramine and maprotiline.

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1980, The American journal of psychiatry.

A Word to the Wise About Intranasal Esketamine.

A. Schatzberg, 2019, The American journal of psychiatry.

Diagnostic differences in verbal learning strategies and verbal memory in patients with mood disorders and psychotic disorders

A. Schatzberg, J. Keller, R. Gomez, 2018, Psychiatry Research.

The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression

A. Schatzberg, J. Keller, L. Tennakoon, 2012, Psychiatry Research.

Current issues in the classification of psychotic major depression.

A. Schatzberg, M. Maj, J. Keller, 2007, Schizophrenia bulletin.

New Paradigm for Treating Recurrent Depression: From Symptom Control to Managing Enduring Vulnerabilities

A. Schatzberg, 2006, CNS Spectrums.

Social stress-related behavior affects hippocampal cell proliferation in mice

K. J. Parker, D. M. Lyons, A. Schatzberg, 2006, Physiology & Behavior.

Coding SNPs included in exon arrays for the study of psychiatric disorders

E G Jones, R. Myers, H. Akil, 2008, Molecular Psychiatry.

Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.

M. Keller, A. Schatzberg, R. Hirschfeld, 1995, Psychopharmacology bulletin.

Abstracts from the 3rd International Forum on Mood and Anxiety Disorders, November 27-30, 2002, Monte-Carlo

A. Schatzberg, G. Murphy, 2002, International journal of psychiatry in clinical practice.

The journal of psychiatric research celebrates its 50th anniversary in 2011

F. Holsboer, A. Schatzberg, 2011 .

Social Perspectives on Mood Disorders

David R. Williams, D. Kupfer, D. Stein, 2006 .

The role of dopamine in psychotic depression.

A. Schatzberg, J. Posener, A. Rothschild, 1995 .

Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder

A. Schatzberg, M. Province, J. Posener, 2004, Psychoneuroendocrinology.

Achieving Remission and Favorable Outcomes in Patients with Depression/Anxiety and Substance use Disorders

A. Schatzberg, 2008, CNS Spectrums.

Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats

A. Schatzberg, D. L. Wong, T. Bengoechea, 1999, Brain Research.

Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).

A. Schatzberg, A. Hoffman, J. Chu, 2001, The Journal of clinical endocrinology and metabolism.

Normal HPA Axis and Rhythm, Exemplary Sleep Disorders

A. Schatzberg, T. Buckley, S. Sleep, 2005 .

Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients

A. Schatzberg, R. Okada, Ashleigh E. Smith, 2023, medRxiv.

Trazodone in Treatment-resistant Depression: An Open Study

A. Schatzberg, J. Cole, J. Cole, 1981 .

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

J. Markowitz, B. Rothbaum, A. Rush, 2000, The New England journal of medicine.

Empirical comparisons of malpractice claims of different medical specialties

A. Schatzberg, James D. Reich, 2015 .

An overview of vortioxetine.

M. Thase, A. Schatzberg, P. Blier, 2014, Journal of Clinical Psychiatry.

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.

John P. Rice, Simon C. Potter, Melissa J. Green, 2018, Cell.

The hypothalamic-pituitary-adrenal axis in alcoholics.

A. Schatzberg, J. R. de la Fuente, A. Rosenbaum, 1983, Alcoholism, clinical and experimental research.

Nonlinear relationship between early life stress exposure and subsequent resilience in monkeys

K. J. Parker, D. M. Lyons, A. Schatzberg, 2019, Scientific Reports.

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

A. Schatzberg, E. Miyawaki, M. Albanese, 1995, Journal of clinical psychopharmacology.

Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder.

J. Markowitz, B. Rothbaum, M. Trivedi, 2017, The Journal of clinical psychiatry.

Hypothalamic-pituitary-adrenal axis physiology and cognitive control of behavior in stress inoculated

K. J. Parker, D. M. Lyons, A. Schatzberg, 2011 .

Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)

M. Fava, M. Trivedi, A. Schatzberg, 2018, Molecular Psychiatry.

Serotonin activity in psychotic (delusional) major depression.

A. Schatzberg, A. Rothschild, 1992, The Journal of clinical psychiatry.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

R. Shelton, M. Trivedi, M. Thase, 2007, Biological Psychiatry.

Stress amplifies sex differences in primate prefrontal profiles of gene expression

D. M. Lyons, D. Absher, R. Myers, 2017, Biology of Sex Differences.

The silver lining of recent effectiveness trials

A. Schatzberg, 2009, World psychiatry : official journal of the World Psychiatric Association.

WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?

C. Nemeroff, A. Schatzberg, D. Newport, 2016, Depression and anxiety.

Use of nefazodone in major depression

A. Schatzberg, Maureen R. Prather, 2002 .

Manual of clinical psychopharmacology, 3rd ed.

A. Schatzberg, C. Debattista, J. Cole, 1997 .

Diagnosis and Classification

A. Schatzberg, C. Debattista, 2015 .

The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study.

A. Schatzberg, Vandana Duggal, T. Buckley, 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Suicide in San Francisco, CA: a comparison of Caucasian and Asian groups, 1987-1994.

A. Schatzberg, B. Bongar, J. Shiang, 1997, Suicide & life-threatening behavior.

Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care

C. Nemeroff, A. Schatzberg, 1999 .

Book Forum TEXTBOOKS

C. Nemeroff, A. Schatzberg, 2011 .

Duloxetine for the treatment of major depressive disorder.

M. Detke, C. Nemeroff, A. Schatzberg, 2002, Psychopharmacology bulletin.

For submission to Psychoneuroendocrinology Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: a meta-analysis

A. Schatzberg, V. Mondelli, D. Enache, 2019 .

Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder

S. Potkin, A. Schatzberg, B. Rollins, 2015, Translational Psychiatry.

The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls.

Melissa J. Green, Janice M. Fullerton, Robert C. Thompson, 2019, Biological psychiatry.

Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry

D. Absher, P. Muglia, M. Boehnke, 2009, Proceedings of the National Academy of Sciences of the United States of America.

Using chronic pain to predict depressive morbidity in the general population.

A. Schatzberg, M. Ohayon, 2003, Archives of general psychiatry.

Functional connectivity changes with rapid remission from moderate-to-severe major depressive disorder

A. Schatzberg, K. Sudheimer, K. Stimpson, 2021 .

Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5‐A3‐B4) predict severity of nicotine addiction and response to smoking cessation therapy

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

J. Lieberman, J. Markowitz, S. Kanba, 2007, The international journal of neuropsychopharmacology.

Disrupted amygdalar subregion functional connectivity and evidence for a compensatory network in generalized anxiety disorder

Katherine E. Prater, M. Greicius, V. Menon, 2009, NeuroImage.

The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.

Robert C. Thompson, R. Myers, H. Akil, 2016, Journal of psychiatric research.

The unique impact of late-life bereavement and prolonged grief on diurnal cortisol.

A. Schatzberg, Vincent Rozalski, J. Holland, 2014, The journals of gerontology. Series B, Psychological sciences and social sciences.

Connective Tissue Growth Factor Is a Novel Prodepressant

Robert C. Thompson, R. Myers, H. Akil, 2018, Biological Psychiatry.

Response to the presidential address.

A. Schatzberg, 2009, The American journal of psychiatry.

FKBP5 polymorphisms and antidepressant response in geriatric depression

L. Lazzeroni, A. Schatzberg, G. Murphy, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression

Jeremy D. Cohen, A. Reiss, A. Schatzberg, 2013, Psychiatry Research: Neuroimaging.

Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.

K. J. Parker, A. Schatzberg, H. Kenna, 2014, Journal of psychiatric research.

Fine-tuning our diagnosis and treatment of depression

A. Schatzberg, M. Ohayon, 2006 .

Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders.

A. Etkin, A. Schatzberg, 2011, The American journal of psychiatry.

Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.

J. Mooney, A. Schatzberg, J. Schildkraut, 1991, Journal of clinical psychopharmacology.

HPA Axis in Major Depression: Cortisol, Clinical Symptomatology, and Genetic Variation Predict Cognition

A. Schatzberg, J. Keller, G. Williams, 2016, Molecular Psychiatry.